Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Cells（2019）
关键词
non-alcoholic steatohepatitis (NASH),non-alcoholic fatty liver disease (NAFLD),peroxisome proliferator-activated receptor (PPAR),elafibranor,lanifibranor,saroglitazar,pioglitazone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要